You are here

Article info

Article menu
Download PDFPDF
Review
Neoadjuvant chemotherapy in early-stage cervical cancer (<2 cm) before conization for fertility preservation: is there any advantage over upfront conization?

Authors

  • Florencia Noll Department of Gynecologic Oncology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina Department of Gynecology, Section of Gynecologic Oncology, Sanatorio Allende, Cordoba, Argentina PubMed articlesGoogle scholar articles
  • Ana Tatiana Palacios Torres Gynecologic Oncology, Fundacion Universitaria de Ciencias de la Salud - FUCS, Hospital de San José, Bogota, Colombia PubMed articlesGoogle scholar articles
  • Pablo Pecci Gynecologic Oncology, Centro Oncologico Puerto Madryn, Chubut, Argentina Gynecologic Oncology, Centro de Diagnóstico Roca, Trelew, Argentina PubMed articlesGoogle scholar articles
  • Sergio Martin Lucchini Department of Gynecology, Section of Gynecologic Oncology, Sanatorio Allende, Cordoba, Argentina PubMed articlesGoogle scholar articles
  • Fernando Heredia Gynecologic and Obstetrics Department, Faculty of Medicine, Universidad de Concepción, Concepción, Chile Minimally Invasive and Robotic Gynecology Unit, Clínica Andes Salud, Concepción, Chile PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Florencia Noll, Gynecologic Oncology, Hospital Italiano de Buenos Aires, Buenos Aires C1199, Argentina; florencia.noll{at}hospitalitaliano.org.ar
View Full Text

Citation

Noll F, Palacios Torres AT, Pecci P, et al
Neoadjuvant chemotherapy in early-stage cervical cancer (<2 cm) before conization for fertility preservation: is there any advantage over upfront conization?
International Journal of Gynecologic Cancer 2021;31:379-386.

Publication history

  • Received September 15, 2020
  • Revision received January 18, 2021
  • Accepted January 21, 2021
  • First published March 1, 2021.
Online issue publication 
March 01, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.